STAAR Surgical Company

US$25.21As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:STAAHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR 11.53%
Div yield —
ROE 0.15%
Medical Instruments & Supplies
Beta (5Y) 1.20
PE TTM 2,385
TSR TTM (2.55%)
Mkt cap US$1.266B
ROIC 1.00%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$29
14.94%
(49.71%)
Hold 4|12|3|11|9
3Q26
4Q26
1Q27
2Q27
Earnings per share$
0.43
0.43
0.43
0.43
18.67%
9.70%
12.86%
3.22%
Revenue$M
80.89
84.83
88.47
89.72
9.44%
15.42%
18.56%
15.91%
Peers (US$1.266B)
Cap (US$)
PE
1.716B
—
1.715B
—
1.267B
34.60x
Capital
TTM
5Y
10Y
Leveragex
0.598
2.404
1.556
EBIT/Intx
1.152
0.649
0.472
Own earn%
(42.29)
(62.89)
(66.02)
Sh yield%
24.92
30.08
28.11
Owners
Insiders/Inst%
1.49
66.69
Short interest%
5.84
SBC / revenue%
1.03
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
22
Op margin range%
9–24
$1 testx
—
Incr. ROIC%
13